BP000276-CHM-355: Recombinant Mouse C-C Motif Chemokine 8 (CCL8) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 74 amino acids and having a molecular mass of 8507 Dalton.
Determined by its ability to chemoattract human peripheral blood monocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000276-CHM-316: Recombinant Human C-C Motif Chemokine 8 (CCL8) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 76 amino acids and having a molecular mass of 8904 Dalton.
The biological activity was determined by measuring the dose dependent mobilization of intracellular calcium (calcium flux) with human THP-1 cells. Significant calcium mobilization is observed with 500 ug/ml of recombinant human MCP-2. Human MCP-2 also induces dose dependent chemotaxis of human THP-1 cells with an ED50=30-100 ug/ml corresponding to a Specific Activity of 10,000-33,334 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000277-CHM-280: Recombinant Rat C-C Motif Chemokine 7 (CCL7) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood monocytes using a concentration range of 50.0-300.0 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000277-CHM-317: Recombinant Human C-C Motif Chemokine 7 (CCL7) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 76 amino acids and having a molecular mass of 9011 Dalton.
The specific activity as determined by the ability of MCP-3 to chemoattract human peripheral blood at 8 - 80 ug/ml corresponding to a Specific Activity of 12,500-125,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000277-CHM-318: Recombinant Mouse C-C Motif Chemokine 7 (CCL7) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 74 amino acids and having a molecular mass of 8510 Dalton.
The specific activity as determined by the ability of Mouse MCP-3 to chemoattract Balb/C mouse spleen MNCs at 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000303-CHM-361: Recombinant Human C-C Motif Chemokine 5 (CCL5) Protein, His Tag
Source: E. coli-derived.
A single, non-glycosylated, Polypeptide chain containing 68 amino acids fragment (24-91) having a total molecular mass of 17.5 kDa and fused with a 4.5 kDa amino-terminal hexahistidine tag.
Purity: > 95% by SDS-PAGE.BP000303-CHM-342: Recombinant Mouse C-C Motif Chemokine 5 (CCL5) Protein
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 68 amino acids and having a molecular mass of 7876 Dalton.
The activity is determined by the ability to chemoattract total human lymphocytes and murine T-cells at a concentration between 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000303-CHM-328: Recombinant Human C-C Motif Chemokine 5 (CCL5) Protein
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 68 amino acids and having a molecular mass of 7809.2 Dalton.
The activity is determined by the chemoattract of human blood monocytes at a concentration between 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000303-CHM-352: Recombinant Rat C-C Motif Chemokine 5 (CCL5) Protein
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 68 amino acids and having a molecular mass of 7876 Dalton.
The activity is determined by the ability to chemoattract total human lymphocytes and murine T-cells at a concentration between 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000292-CHM-263: Recombinant Human C-C Motif Chemokine 3-Like 1 (CCL3L1) Protein
Source: E. coli-derived.
The biological activity was determined by its ability to chemoattract human monocytes using a concentration range of 1.0-10.0 ug/ml.
Purity: > 97% by RP-HPLC and SDS-PAGE.